UCB: DATA IS THE NEW DRUG Case Study Solution

Weaknesses

Along with strengths, company also possesses some of the weaknesses which the company should consider to eliminate in order to remain competitive and for the sake of increasing its profitability. The company used to operate in limited segments of the pharmaceutical products which are mainly concerned with the severe disease possessed by the patients. Hence, the focus of operations of the company in limited segments enables the company to work on other general and less severe diseases which is not allowing the company to exploit further opportunities. Moreover, the company is operating in almost 40 countries around the world but the company is well recognized in just few countries which is evident from the fact the most of the revenue of the company is generated from operations in Europe and the United States of America.

Opportunities

There are number of opportunities which are available to the company which includes advancement in technology and implementation of advanced data analytics technology to manage, collect and ponder over data insight which could assist the company in providing solutions through the scientific data and research to the patients. The other opportunity available to the company is the development of innovative therapies and medicine in the treatment of a disease called epilepsy. The company has not concentrated on epilepsy which provides the company opportunity to focus on developing solution for this particular disease to enhance the profitability as well as the recognition of the company worldwide. Due to less recognition of the company around the world the company should focus on conducting awareness campaigns and sessions in different countries regarding the severe disease which will enable the individuals to determine the purpose of UCB pharmaceuticals and their medication.

Threats

The number of threats are available to the company in this highly competitive and regulated industry which could overtake the company’s revenues and profitability margins. As the company major revenues are derived from Europe and America, the instability in the economic conditions of these zones could affect the revenue and profitability of the company due to instability of the currency prevailing in Eurozone. Moreover, with the advancement in technological development the industry is becoming more competitive. Therefore, the company should be aware of the technological development in the industry and thrive to focus on the adoption of technology advancement required by the company in near future.

Alternative 1

One of the major alternatives available to the company to improve its efficiency of operations and enhance the outcome is to focus on gaining the insight of the information instead of wasting time in managing and collecting information. Moreover, the company should not adopt or focus on the technologies to collect and manage internal and external information instead of which the company should keep its core focus on gaining the insights of that information. Although, to get insight of the information the company requires to collect and manage the data. Therefore, the company should consider to acquire services of other companies in order to gain insight upon the information collected and managed by the company. Hence, this alternative will allow the company to save time and make an investment on the research and development and acquire early results to implement on the patients to provide them solution and enhance their experience.

Alternative 2

The company should focus on investing and developing the technological advancement regarding data analytics to come up with the solution of severe disease possessed by the patients. The company has also implemented analytics as a service (AAAS) conceptual framework to enhance the technology of gaining insight into the data so that the company could connect the data to the patients and provide best possible solution regarding the treatment of disease required by the patients. Moreover, the development and investment in technology will also enable the company to remain competitive due to enhancement in research and development of the company and development of innovation and ideas to remain ahead of the competitors.

Evaluation of Alternatives

Comparing both the alternative enables to determine that the alternative one provides a temporary and less reliable solution of gaining insight into the data in comparison with the alternative two, whereas the alternative two provides a permanent solution by enhancing the company’s technology and the development of research and development department of the company. The alternative one is less reliable because the data can be analyzed more efficiently by the company who generates it rather than the outside company which will acquire and analyze the data. Moreover, the enhancement in technological development of the company will also provide a competitive edge to the company over its competitors in the future due to the innovative research and ideas including the data analytic techniques possessed by the company.

Recommendation

Analyzing the two alternatives mentioned above, it is found out that the company should implement the alternative two for adopting and enhancing the technological development through investment in research and development. The data analytics development within the company will enable the company to analyze the data and develop innovative ideas and research which could assist the company in gaining long term benefit as well as development of company’s information technology will assist the company to remain competitive within the industry. Hence, implementing the technological development is more beneficial for the company than outsourcing the services of different company to analyze the insight of the data which is collected and managed through internal and external health care providing sources.

Conclusion

After defining the company’s problems and conducting the company analysis in alignment with the technological development and business objectives, it is found out that the pharmaceutical industry is a highly regulated industry and possesses potential gains in generating revenues. Therefore, it is recognized that the company should strive harder to remain competitive within the industry by adopting the technologically advanced data analytics information system to enhance the patients’ experience and provide them the best available solution according to the data collected and managed by the company. Hence, the company should be adaptable and have an improvement in order to gain the position as one of the leading giants within the industry............

This is just a sample partical work. Please place the order on the website to get your own originally done case solution.

Related Case Solutions & Analyses:

Jack Hughes Founder and Chairman of TopCoder In-Class Comments 04082011 Video Should You Have a Global Strategy Merger of Equals: The Integration of Mellon Financial and The Bank of New York (C) Hedging with Forwards and Futures 1366 Technologies Bank of America (B) Destiny WebSolutions Inc. iQmetrix-Humanity: Negotiating a Partner Agreement-Maurice Thibodeau’s Perspective Capital Structure and Firm Performance: Evidence from Airline Industry of USA Leadership Skills